Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

被引：0
|
作者：
Satoshi Watanabe
Junta Tanaka
Takeshi Ota
Rie Kondo
Hiroshi Tanaka
Hiroshi Kagamu
Kosuke Ichikawa
Jun Koshio
Junko Baba
Takao Miyabayashi
Ichiei Narita
Hirohisa Yoshizawa
机构：
[1] Niigata University Medical and Dental Hospital,Department of Medicine (II)
[2] Niigata University Medical and Dental Hospital,Bioscience Medical Research Center
来源：
BMC Cancer | / 11卷
关键词：
Overall Survival; Gefitinib; Erlotinib; NSCLC Patient; Disease Control Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer
    Takeshi Masuda
    Satoru Miura
    Yuki Sato
    Motoko Tachihara
    Akihiro Bessho
    Atsushi Nakamura
    Taichi Miyawaki
    Kohei Yoshimine
    Masahide Mori
    Hideaki Shiraishi
    Kosuke Hamai
    Koji Haratani
    Sumiko Maeda
    Eriko Tabata
    Chiyoe Kitagawa
    Junko Tanizaki
    Takumi Imai
    Shohei Nogami
    Nobuyuki Yamamoto
    Kazuhiko Nakagawa
    Noboru Hattori
    Scientific Reports, 13
  • [32] Volumetric Tumor Growth in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutations During EGFR-Tyrosine Kinase Inhibitor Therapy Developing Criteria to Continue Therapy Beyond RECIST Progression
    Nishino, Mizuki
    Dahlberg, Suzanne E.
    Cardarella, Stephanie
    Jackman, David M.
    Rabin, Michael S.
    Ramaiya, Nikhil H.
    Hatabu, Hiroto
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CANCER, 2013, 119 (21) : 3761 - 3768
  • [33] EGFR tyrosine kinase inhibitor in advanced non-small cell lung cancer with wild-type EGFR
    Wang, Z.
    Wu, Y. L.
    Yang, J.
    Wang, B.
    Huang, Y.
    Zhou, Q.
    Xu, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] EGFR Tyrosine Kinase Inhibitor and Chemotherapy in EGFR Mutation-Positive Non-Small Cell Lung Cancer
    Nishino, Kazumi
    Kimura, Madoka
    Inoue, Takako
    Uchida, Junji
    Kumagai, Toru
    Imamura, Fumio
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [35] Efficacy of EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer Patients Harboring Different Types of EGFR Mutations:A Retrospective Analysis
    刘华丽
    韩光
    彭敏
    翁一鸣
    袁静萍
    杨桂芳
    于金明
    宋启斌
    Current Medical Science, 2017, 37 (06) : 864 - 872
  • [36] Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
    Hua-li Liu
    Guang Han
    Min Peng
    Yi-ming Weng
    Jing-ping Yuan
    Gui-fang Yang
    Jin-ming Yu
    Qi-bin Song
    Current Medical Science, 2017, 37 : 864 - 872
  • [37] Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis
    Liu, Hua-li
    Han, Guang
    Peng, Min
    Weng, Yi-ming
    Yuan, Jing-ping
    Yang, Gui-fang
    Yu, Jin-ming
    Song, Qi-bin
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2017, 37 (06) : 864 - 872
  • [38] Treatment and prognosis after progression in long-term responders to EGFR-tyrosine kinase inhibitor in advanced non-small cell lung cancer
    Song, Zhengbo
    Zhang, Yiping
    ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (01) : 107 - 111
  • [39] New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer
    Doebele, Robert C.
    Oton, Ana B.
    Peled, Nir
    Camidge, D. Ross
    Bunn, Paul A., Jr.
    LUNG CANCER, 2010, 69 (01) : 1 - 12
  • [40] The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations
    Hidekazu Suzuki
    Tomonori Hirashima
    Norio Okamoto
    Tadahiro Yamadori
    Motohiro Tamiya
    Naoko Morishita
    Takayuki Shiroyama
    Tomoyuki Otsuka
    Kanako Kitai
    Ichiro Kawase
    ChineseJournalofCancer, 2013, 32 (03) : 136 - 140
12345